WallStSmart

Covista Inc. (CVSA)vsMynd.ai, Inc. (MYND)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Covista Inc. generates 800% more annual revenue ($1.89B vs $209.80M). CVSA leads profitability with a 13.4% profit margin vs -36.6%. CVSA earns a higher WallStSmart Score of 67/100 (B-).

CVSA

Strong Buy

67

out of 100

Grade: B-

Growth: 5.3Profit: 7.5Value: 8.3Quality: 5.0

MYND

Avoid

23

out of 100

Grade: F

Growth: 5.3Profit: 2.0Value: 5.0Quality: 2.5
Piotroski: 3/9Altman Z: -1.63
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CVSASignificantly Overvalued (N/A)

Margin of Safety

N/A

Fair Value

$97.23

Current Price

$113.08

$15.85 premium

UndervaluedFair: $97.23Overvalued

Intrinsic value data unavailable for MYND.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CVSA4 strengths · Avg: 8.0/10
PEG RatioValuation
0.818/10

Growing faster than its price suggests

P/E RatioValuation
16.1x8/10

Attractively priced relative to earnings

Price/BookValuation
2.8x8/10

Reasonable price relative to book value

Operating MarginProfitability
22.9%8/10

Strong operational efficiency at 22.9%

MYND1 strengths · Avg: 8.0/10
Price/BookValuation
2.8x8/10

Reasonable price relative to book value

Areas to Watch

CVSA1 concerns · Avg: 4.0/10
EPS GrowthGrowth
4.7%4/10

4.7% earnings growth

MYND4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$18.81M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-2.0%2/10

ROE of -2.0% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : CVSA

The strongest argument for CVSA centers on PEG Ratio, P/E Ratio, Price/Book. Revenue growth of 12.4% demonstrates continued momentum. PEG of 0.81 suggests the stock is reasonably priced for its growth.

Bull Case : MYND

The strongest argument for MYND centers on Price/Book.

Bear Case : CVSA

The primary concerns for CVSA are EPS Growth.

Bear Case : MYND

The primary concerns for MYND are EPS Growth, Market Cap, Piotroski F-Score. Debt-to-equity of 11.88 is elevated, increasing financial risk.

Key Dynamics to Monitor

CVSA profiles as a value stock while MYND is a turnaround play — different risk/reward profiles.

MYND carries more volatility with a beta of 4.60 — expect wider price swings.

CVSA is growing revenue faster at 12.4% — sustainability is the question.

CVSA generates stronger free cash flow (15M), providing more financial flexibility.

Bottom Line

CVSA scores higher overall (67/100 vs 23/100) and 12.4% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Covista Inc.

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA

Covista Inc., provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. The company is headquartered in Chicago, Illinois.

Mynd.ai, Inc.

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA

MYnd Analytics, Inc. is a predictive analytics company primarily in the United States. The company is headquartered in Mission Viejo, California.

Visit Website →

Want to dig deeper into these stocks?